0000905148-26-004065.txt : 20260902 0000905148-26-004065.hdr.sgml : 20260902 20260902163031 ACCESSION NUMBER: 0000905148-26-004065 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20260831 FILED AS OF DATE: 20260902 DATE AS OF CHANGE: 20260902 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Levin Michaela CENTRAL INDEX KEY: 0002151012 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-41551 FILM NUMBER: 261355311 MAIL ADDRESS: STREET 1: 480 ARSENAL WAY STREET 2: SUITE 100 CITY: WATERTOWN STATE: MA ZIP: 02472 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Acrivon Therapeutics, Inc. CENTRAL INDEX KEY: 0001781174 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences EIN: 825125532 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 480 ARSENAL WAY, SUITE 100 CITY: WATERTOWN STATE: MA ZIP: 02472 BUSINESS PHONE: 617-207-8979 MAIL ADDRESS: STREET 1: 480 ARSENAL WAY, SUITE 100 CITY: WATERTOWN STATE: MA ZIP: 02472 4 1 form4.xml FORM 4 X0609 4 2026-08-31 0001781174 Acrivon Therapeutics, Inc. ACRV 0002151012 Levin Michaela false C/O ACRIVON THERAPEUTICS, INC. 480 ARSENAL WAY, SUITE 100 WATERTOWN MA 02472 false true false false Chief Business Officer false Common Stock 2026-08-31 4 A false 30000 0 A 30000 D Stock Option (Right to Buy) 2.09 2026-08-31 4 A false 130000 0 A 2036-08-30 Common Stock 130000 130000 D These shares represent restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of the Issuer's Common Stock. These RSUs shall vest in full on September 1, 2027, subject to the Reporting Person's continuous service through such vesting date. Twenty-five percent (25%) of the shares subject to the option vest on September 1, 2027, and the remaining shares subject to the option vest in 36 substantially equal monthly installments thereafter, in each case subject to the Reporting Person's continuous service through each vesting date. /s/ Adam D. Levy, Attorney-in-Fact 2026-09-02